Tasigna Atherosclerosis Lawsuit News
Information and News About Tasigna Atherosclerosis Lawsuits
Tasigna Patients Are Warned of The Risk of Sudden Death | 5/13/2019
Novartis has taken measures, updating their US website's homepage, to alert the public of the FDA's QT prolongation and atherosclerosis warnings...READ MORE
Tasigna's Atherosclerosis Risk Is Well-Documented By Researchers For Peer-Reviewed Medical Publications | 5/8/2019
Novartis has buried critical Tasigna atherosclerosis warnings deep in its website where it is unlikely to draw much attention...READ MORE
Tasigna's Atherosclerosis Side Effect Is Not Forgotten | 4/17/2019
Novartis is stealing headlines for Tasigna's cancer-fighting effectiveness, but the drug's atherosclerosis side effects remain as deadly as ever...READ MORE
Trying Tasigna As A Last Resort May Make Sense To Terminally Ill Cancer Patients | 4/12/2019
Tasigna carries severe severe atherosclerosis making the drug a sensible choice for only the most hopeless cancer patients...READ MORE
Novartis Claim Tasigna Can Help Parkinson's Patients is Met With Skepticism | 4/4/2019
Given the fraud and deception that Novartis has admitted to in the past, it is hard to take any medical breakthrough the company claims seriously...READ MORE
Novartis Failed To Warn American Doctors Who In Turn Failed To Warn Patients of Tasigna's Atherosclerosis Risks | 3/20/2019
Patients have a right to know if the drug they are being given is more deadly than the disease it is intended to treat and drug companies have a responsibility to inform doctors...READ MORE
Tasigna Is Being Repurposed To Treat Parkinson's Disease | 3/14/2019
Tasigna's severe side effects are a fast-fading memory as Novartis promotes Tasigna in every possible market...READ MORE
Some Patient Can Cease Taking Tasigna But They May Have Already Developed Atherosclerosis | 3/12/2019
Just because a patient is cancer-free doesn't mean that his health problems are over...READ MORE
Health Experts Warn of Potentially Deadly Tasigna Drug Interactions | 3/5/2019
Leading health professionals have reported that certain drug interactions with Tasigna can be fatal...READ MORE
The Potential To Someday Stop Tasigna Treatments Should Not Be An Incentive To Take The Drug | 2/28/2019
Billion dollar fines fail to slow Novartis' use of unethical and illegal sales tactics to sell their dangerous anti-cancer drug...READ MORE
Tasigna Studies Show The Drug Should Be Taken As A Last Resort | 2/24/2019
Tasigna is being over-promoted as a breakthrough cancer drug, encouraging its overuse...READ MORE
Cancer Doctors and Medical Websites Should Take Tasigna's Atherosclerosis Risks More Seriously | 2/18/2019
Doctors know that cancer patients have much on their minds when choosing a cancer treatment and may not think the patients can handle making a Tasigna atherosclerosis decision...READ MORE
The FDA May Be Putting Children's Lives In Danger By Ignoring Tasigna's Atherosclerosis Risk | 2/12/2019
The FDA is rolling the dice when one adds the already high rates of atherosclerosis in children given anti-cancer drugs with Tasigna's admission of being the most toxic drug of them all...READ MORE
The FDA May Have Overlooked Tasigna's Atherosclerosis Side Effect When Approving its Usage by Children | 2/5/2019
Tasigna may be a revolutionary way to treat cancer but may cause other diseases equally bad or worse...READ MORE
Children With Cancer May Now Start Taking Tasigna | 1/31/2019
The US FDA must have overlooked that Tasigna has been shown to produce irreversible atherosclerosis in an unacceptably high number of patients...READ MORE
Studies Reported by Leading Experts Focus on Tasigna Toxicity | 1/25/2019
No study of Tasigna's effects on a patient's heart health would be complete without checking to see what the world's leading authority on blood had to say...READ MORE
Novartis Has a History of Deceptive Sale Practices That Taints Their Credibility | 1/22/2019
Novartis has paid hundreds of millions of dollars in fines to the US, EU, Greece, Japan, and Korea for the fraud it has perpetrated on government health care systems around the world...READ MORE
Novartis Changes Tasigna's Label But Not Its Toxicity | 1/16/2019
Some patients can stop taking Tasigna at some point but the drug's long-term side effects such as atherosclerosis will continue...READ MORE
Tasigna Doctors May Be Ignoring Atherosclerosis Risks | 1/11/2019
Tasigna cancer patients must watch for the signs that they have started to develop atherosclerosis...READ MORE
Cancer Doctors Prescribing Tasigna Should Be Trained Like Heart Specialists | 1/8/2019
The adverse side effects of Tasigna force oncologists to test their patients for heart and blood abnormalities to avoid heart disease and at times sudden death...READ MORE
Tasigna is Effective in Treating Chronic Myeloid Leukemia | 1/1/2019
People should be aware of the symptoms of leukemia as early as possible in order to treat the disease effectively...READ MORE
Early Warning Signs of Chronic Myeloid Leukemia (CML) | 12/5/2018
The early diagnosis of CML increases the effectiveness of Tasigna chemotherapy treatments...READ MORE
CML Patients in Remission May Discontinue Taking Tasigna | 12/1/2018
Many of the adverse side effects of Tasigna chemotherapy can be avoided since for some the drug may be discontinued...READ MORE
Tasigna's Atherosclerosis Warnings is Rarely Seen by Cancer Patients | 11/28/2018
Even a black box warning can go unnoticed by patients with cancer that are fighting for their lives...READ MORE
Novartis' Failure to Warn the FDA May Have Led to Atherosclerosis in As Many As One in Four Tasigna Patients | 11/12/2018
Novartis has failed to officially warn cancer patients in the US that Tasigna can cause a disease even more deadly than cancer...READ MORE
Novartis Highlights Tasigna's Effectiveness yet Downplays The Drug's Deadly Side Effects | 11/8/2018
There is a seemingly endless list of life-threatening side effects from taking the potent, yet highly toxic anti-cancer drug Tasigna and they make a person wonder if the treatment is not even worse than the disease...READ MORE
Novartis Takes Advantage of Tasigna's Catch 22 | 10/30/2018
Only the most distressed and terminal cancer patients are given Tasigna, therefore the fact that they could develop atherosclerosis is merely an afterthought...READ MORE
Tasigna Atherosclerosis Ignored by Novartis Celebrity Spokesperson | 10/24/2018
Tasigna patients could require coronary bypass surgery...READ MORE
Oncologists May Be Ignoring the Cardiovascular Side Effects of Tasigna | 10/16/2018
Oncologists are thrilled with Tasigna's cancer-fighting results yet choose to ignore the greater risk of atherosclerosis Tasigna chemotherapy poses...READ MORE
The FDA Atherosclerosis Warning Came Too Late for Tasigna Patients in the United States | 10/8/2018
Novartis warned Canadians of the atherosclerosis health risk of Tasigna while simultaneously increasing the sales of the drug in the billion-dollar US market...READ MORE
One-Third of Tasigna Patients Could Face Coronary Bypass Surgery | 10/4/2018
Tasigna may be the strongest drug on the market in fighting cancer but the side effects make the risks greater than the benefits...READ MORE
Billion Dollar Fines Are Just a Cost of Doing Business For Novartis | 10/2/2018
Novartis has a history of devious behavior when it comes to marketing dangerous and potentially deadly drugs worldwide...READ MORE
Cancer Patients Should View Novartis' New Tasigna Label With Scepticism | 9/28/2018
Swiss pharmaceutical maker Novartis AG has a history of illegally and overzealously marketing their drugs while conveniently neglecting to mention their side effects...READ MORE
Novartis Boasts of Tasigna's Effectiveness While Ignoring the Atherosclerosis Side Effects | 9/27/2018
The old saying "if it sounds too good to be true, it probably is," applies perfectly to a recent announcement by Novartis, maker of the anti-cancer drug Tasigna...READ MORE
Tasigna May Be One Of The Most Deadly Drugs On The Market Today | 9/25/2018
According to the National Institute of Health and Novartis may well have known about it years ago...READ MORE
NBA Star's Arterial Blockage May Have Been Caused by Taking Tasigna | 9/22/2018
Kareem Abdul Jabbar was required to undergo "quadruple coronary bypass surgery" despite being a vegan and living a healthy lifestyle. His only vice might have been using the anti-cancer drug Tasigna...READ MORE
Taxpayers Saved Billions By Novartis AG Whistleblower | 9/20/2018
The False Claims Act is the leading tool for corporate insiders to come forward and report what they know to the US Department of Justice...READ MORE
Tasigna Carries The Unacceptable Risk of Developing Atherosclerosis and Amputation | 9/19/2018
There is growing evidence that Tasigna patients may be simply trading one deadly disease for another...READ MORE
Tasigna's Cancer-Fighting Success May Be Tempered By The Risk Of Sudden Death | 9/17/2018
Oncologist's enthusiasm over Tasigna's cancer-treating effectiveness may cause them to overlook the drug's deadly side effects...READ MORE
Novartis Pulled No Punches In Warning Canadians About The Atherosclerosis Related Side effects Of Tasigna Yet Said Nothing To Warn Cancer Patients In The United States. | 9/11/2018
Canadian health officials were provided an urgent warning to be aware that Tasigna can cause atherosclerosis while no such warning made its way to the US market...READ MORE
Novartis is a Repeat Offender for Fraudulent Drug Marketing | 8/29/2018
It may be just a matter of time before Novartis puts profits ahead of patient safety in marketing yet another life-threatening drug...READ MORE
Peripheral Artery Disease Plagues Tasigna Patients | 8/27/2018
Tasigna patients relieved to have beaten cancer may now be faced with a death sentence from peripheral artery disease...READ MORE
Patients Could Have Benefited From Gleevec's Generic Alternative | 8/21/2018
Not only does Tasigna ruin a person's health, it costs ten times more than Gleevec's generic competition...READ MORE
Novartis/Tasigna Lawsuit May Seek Punitive Damages | 8/17/2018
Novartis may have withheld its knowledge that Tasigna causes atherosclerosis from the FDA when seeking the drugs initial approval...READ MORE
Tasigna Atherosclerosis Trial Set to Proceed | 8/14/2018
Anti-cancer chemotherapy drugs are so toxic that the body's arteries may be incapable of handling them...READ MORE
Medical Websites Ignore Tasigna's Risks | 8/10/2018
Medical professionals are so enthusiastic about the drug's ability to fight cancer that they are ignoring Tasigna's other life-threatening side effects including sudden death...READ MORE
Novartis haste in rushing Tasigna to market has cost patients their lives | 8/8/2018
Novartis put company profits ahead of human life when they rushed Tasigna to market without properly testing it first...READ MORE
Tasigna's Side Effects Require Special Attention From Prospective Patients | 8/6/2018
When sudden death, amputation, and strokes are taken into account, few patients have been properly informed of the risks of Tasigna...READ MORE
Novartis Whistleblower Receives $12 Million For His Efforts | 7/31/2018
The False Claims Act encourages drug company employees to assists the government in policing Specialty Pharmacies...READ MORE
Tasigna Atherosclerosis Hidden From Americans | 7/30/2018
Canadians were warned about Tasigna but Americans were not...READ MORE
Gleevec Was a Cancer-Curing Miracle Drug | 7/26/2018
Novartis put profits ahead of patient safety when the rushed Tasigna to market. Cancer patients lived longer when taking Gleevec yet Novartis replaced it with Tasigna fearing a drop in corporate profits...READ MORE
Tasigna Stroke Victim's Trial to Proceed in Florida | 7/24/2018
Dennis McWilliams alleges Novartis failed to warn him of the adverse side effects of Tasigna that caused him to have a paralyzing stroke...READ MORE
Novartis Employee Blows Whistle on Tasigna Fraud and Others | 7/20/2018
The FDA forces Novartis to pay $500 million in fines for Medicaid and Medicare fraud for misrepresenting five of its patented drugs including Tasigna...READ MORE
Tasigna Side Effects Are Worse Than Cancer | 7/18/2018
At what point does a cancer patient decide that they are better off waiting to die from cancer rather than undergo Tasigna chemotherapy with all its risks?...READ MORE
Tasigna Cancer Medication Carries More Risks Than Others | 7/11/2018
As if suffering from cancer was not enough, Tasigna patients have to worry about amputations, paralysis and sudden death...READ MORE
Specialty Pharmacists Bribed to Prescribe Tasigna | 7/6/2018
Generic drug competition led to specialty pharmacists refilling Gleevec prescriptions with the more potent Tasigna...READ MORE
Novartis Billion-Dollar Fine for Fraudulent Marketing Tactics | 7/2/2018
Swiss pharmaceutical company Novartis AG was forced to pay the largest fine ever handed down under the US False Claims Act...READ MORE
Tasigna Black Box Warning Addendum | 6/29/2018
Tasigna has so many deadly side effects that an FDA Black Box warning merely scratches the surface...READ MORE
Tasigna Replaced Gleevec and Patients Suffered | 6/25/2018
Novartis replaced Gleevec with Tasigna and for many patients suffering from a rare form of leukemia, the results have been catastrophic...READ MORE
Specialty Pharmacists Selling Tasigna Compromised Ethical Standards | 6/20/2018
Novartis' Tasigna sales reps and specialty pharmacists practice the highest ethical standards so long as profits are not compromised...READ MORE
US Department of Justice Fines Novartis One Billion Dollars | 6/13/2018
Company whistleblower information reveals deceptive and illegal drug sales tactics by Novartis sales representatives...READ MORE
Tasigna Sudden Death Warning | 6/11/2018
Tasigna carries a warning of sudden death, heart attack, stroke and the potentials for amputations ...READ MORE
Tasigna Cancer Treatment Poses Scary Risks | 6/7/2018
The irreversible side effects of anti-cancer drug Tasigna are potentially worse than having cancer itself...READ MORE
Novartis Fraudulent Marketing Deception | 5/29/2018
Novartis sales reps knew Tasigna was linked to atherosclerosis...READ MORE
Tasigna Atherosclerosis Warning Never Made it to the US | 5/25/2018
Novartis may have put profits ahead of public safety when they failed to warn cancer patients in the US like they did in Canada and elsewhere...READ MORE
Novartis Tasigna Anti-Cancer Drug Has Side Effects That Include Sudden Death | 5/22/2018
Novartis salespeople used illegal marketing tactics to hide the deadly side effects of Tasigna that may have cost hundreds of people their lives...READ MORE
Tasigna Replaced Gleevec Under Fraudulent Circumstance | 5/18/2018
It seems as though a drug company will do anything to protect billions of dollars in profits, and view lawsuits as just another cost of doing business...READ MORE
Novartis Held Accountable For Concealing Tasigna Atherosclerosis Risk | 5/15/2018
The deceptive practices of Novartis AG have not escaped government regulators in the United States...READ MORE
Tasigna Chemotherapy Carries a Sudden Death Warning | 5/10/2018
Tasigna doctors must perform a battery of specialized tests on their cancer patients, pre-screening them for existing heart disease and blood abnormalities...READ MORE
Novartis Warns That Tasigna Can Cause Atherosclerosis | 5/6/2018
Sudden death from a heart attack is one of the many side effects of taking Tasigna anti-cancer chemotherapy...READ MORE
Tasigna Poses Atherosclerosis Amputations Risk | 5/3/2018
Anti-cancer chemotherapy drug Tasigna is causing Atherosclerosis and patients often require amputation to treat the disease...READ MORE
Tasigna Rushed to Market to Replace Gleevec | 12/29/2017
The FDA did not require the same testing of Tasigna as it would have if it had been manufactured by a different company...READ MORE
Whistleblower Saves American Taxpayers Millions | 12/22/2017
The False Claims Act encourages drug company employees to report illegal activities and can save taxpayers millions in fraudulent Medicaid and Medicare costs...READ MORE
Gleevec-the Novartis AG Wonder Drug | 12/20/2017
Life-extending cancer chemotherapy drug Gleevec went off patent in July 2015 and Tasigna rushed to market...READ MORE
Tasigna Warnings | 12/18/2017
Research institutes, government health agencies and patients around the globe warn of the link between Tasigna and vascular disease...READ MORE
Tasignas Black Box Warning Links The Drug To Atherosclerosis | 12/15/2017
Patients taking Tasigna should be constantly aware of the drug's potential to cause atherosclerosis and to watch for the signs they are developing the disease...READ MORE
Novartis Fails To Warn The U.S. Medical Community About The Side Effects of Tasigna | 12/11/2017
It is well-documented that Swiss pharmaceutical company Novartis AG knew that Tasigna caused atherosclerosis and deliberately kept the information from the American medical community...READ MORE
Tasigna Replaces Gleevec as the Novartis AGs Signature Anti-Cancer Chemotherapy Drug | 12/6/2017
Novartis AG marketed Tasigna to specialty pharmacies in the US without advising them of the Canadian health warnings...READ MORE
The Unmistakable Signs of Peripheral Artery Disease | 12/1/2017
Cancer doctors closely monitor their Tasigna chemotherapy patients for the signs that they may have PAD...READ MORE
Whistleblower Causes Public Alert to Tasigna Side Effects | 11/27/2017
Whistleblowers are encouraged to come forward when corporate activities put public health in danger...READ MORE
The Estate of a California Man is Suing Novartis | 11/20/2017
The surviving family members allege in court that Novartis knew of the atherosclerosis risks Tasigna posed and failed to warn them...READ MORE
Ex-Novartis Salesmanager Blows The Whistle On Illegal Drug Marketing | 11/13/2017
Whistleblower lawsuit against Novartis helps to shed light on the lengths drug companies go to sell their product...READ MORE
U.S. Cancer Patients Receive Tasigna Atherosclerosis Warning | 11/6/2017
Tasigna maker warns that the drug can have serious life-threatening side effects...READ MORE
Novartis Marketed Tasigna to Replace Gleevec | 11/3/2017
Economics may be the reason Tasigna was brought to market to replace Gleevec...READ MORE
Leukemia Patients May Suffer From Heart Disease as Well | 10/30/2017
Tasigna anti-cancer chemotherapy has the deadly side effect of causing atherosclerosis, a hardening, and thickening of major arteries leading to the extremities, heart and brain. ...READ MORE
Novartis' Potentially Misleading Drug Marketing Campaign | 10/23/2017
Novartis may have misled American cancer doctors and the general public when it brought Tasigna to the market...READ MORE
Health Canada Issued a Tasigna Health Warning In 2013 | 10/16/2017
Canadian health officials warn of life-threatening side effects of anti-cancer chemotherapy drug Tasigna, telling doctors in Canada to take precautions before, during, and after giving patients the drug...READ MORE
Lawsuits Allege Novartis Was Aware of The Side Effects of Tasigna Yet Failed to Warn The American Public | 10/9/2017
A California lawsuit alleges Novartis AG was aware that Tasigna could be linked to atherosclerosis and related diseases years before the American public was so informed...READ MORE
Tasigna Chemotherapy Atherosclerosis-related Side Effects | 10/2/2017
Cancer patients given Tasigna should be on the lookout for the symptoms of atherosclerosis...READ MORE
The Onder Law Firm Seeks to Hold Novartis Accountable for the Suffering Tasigna Has Caused Families | 9/29/2017
Onder Law's compassionate, zealous and experienced personal injury and wrongful death attorneys helping those who have been injured by corporate negligence and greed...READ MORE
Novartis Fails to Warn About Tasigna Atherosclerosis | 9/22/2017
Novartis neglected its responsibility to warn the American public that Tasigna may cause atherosclerosis...READ MORE
Side Effects of Tasigna Cancer Drug Include Atherosclerosis and Peripheral Artery Disease | 9/15/2017
Physical signs to look for it you suspect you have developed atherosclerosis or peripheral arterial disease...READ MORE
Novartis Put Profits Ahead of Patients | 9/7/2017
Novartis AG Failed to Warn America that Tasigna causes heart disease...READ MORE
Novartis Failed to Warn the American Medical Community of the Side Effects of Tasigna | 9/1/2017
Tasigna has been found to cause atherosclerosis and peripheral artery disease in cancer patients being treated with the deadly anti-cancer chemotherapy drug...READ MORE
Atherosclerosis Linked to Tasigna Anti Cancer Drug | 8/18/2017
Tasigna makers Novartis International AG an Anti Cancer Treatment Drug Failed to Give Side Effects Warning to Doctors and Patients ...READ MORE
You Can Sue Novartis If You Have Developed Atherosclerosis-Related Conditions After Taking Tasigna | 8/11/2017
Innocent people have been the victim of Novartis failing to warn American doctors of the extended risks of using the anti-cancer chemotherapy drug Tasigna...READ MORE
Who Can Be Considered A Tasigna Victim | 8/4/2017
Thousands of Americans may be able to file an individual lawsuit against Novartis, maker of the deadly anti-cancer drug Tasigna...READ MORE
Novartis AG makers of Tasigna Failed to Warn Public of the Dangerous Side Effects | 7/14/2017
Tasigna a drug used to treat advanced cancer patients and the makers Novartis AG under fire in a St Louis court of law...READ MORE
Tasigna Anti Cancer Drug Lawsuit | 7/7/2017
The chemotherapy drug Tasigna is used to treat cancer patients in their advanced stages but Novartis AG failed to warn consumers of proven dangerous side effects...READ MORE
Tasigna Drug Warning for Peripheral Arterial Disease | 6/30/2017
Leukemia studies show that the anti-cancer drug Tasigna indicate adverse side effects reactions in treated patients ...READ MORE
Tasigna Cancer Treatment Drug Lawsuit | 6/26/2017
Anti-cancer drug Tasigna patients experience adverse side effects without warning from the makers of the drug...READ MORE
Novartis International AG Lawsuits | 6/23/2017
The makers of Tasigna known as Novartis International AG falsely promoted the drug's effectiveness to cancer doctors ...READ MORE
Lawsuits Against Novartis International AG Makers of Tasigna | 6/21/2017
Multi-billion-dollar Tasigna anti-cancer lawsuit against swiss pharmaceutical giant Novartis International AG...READ MORE
Tasigna Peripheral Artery Disease Warning | 6/19/2017
Healthcare professionals and their patients have been misled by Tasigna anti-cancer drug makers Novartis International AG ...READ MORE
Tasigna Lawsuits Against Drug Makers Novartis | 6/16/2017
The makers Novartis of Tasigna leukemia drug continue to make a huge profit from sales regardless of the link between Tasigna and atherosclerosis caused by the use of the drug...READ MORE
Atherosclerosis of the Aorta Linked to Tasigna Anti-Cancer Drug | 6/12/2017
Tasigna anti-cancer drug is proven to have severe side effects as deadly as the disease it was marketed to treat...READ MORE
Makers of Tasigna Leukemia Drug Lawsuit | 6/9/2017
Novartis AG makers of Tasigna leukemia drug failed to warn US doctors and patients of the potential to develop atherosclerosis...READ MORE
Tasigna a Cancer Drug Treatment | 6/5/2017
Plaque buildup in the arterial walls is one of the symptoms of atherosclerosis treated by Tasigna ...READ MORE
Tasigna Peripheral Arterial Disease | 6/1/2017
Advanced peripheral arterial disease cause from Tasigna side effects include sores and lesions on the feet that do not heal normally...READ MORE
No-Cost, No-Obligation Tasigna Lawsuit Case Review If You or a Loved One Suffered from Tasigna Complications
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.
OnderLaw, LLC -